- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Managed Care Minute: May 9, 2015
A one-minute look at managed care news during the week of May 4, 2015, including global cancer drug spend, movements in telehealth, and changing behavior to reverse poor health.
This week IMS Health reported that total global cancer drug spending hit the $1 billion mark in 2014, up 10.3% from 5 years earlier. This growth was driven by earlier diagnosis, longer treatment duration, and increased effectiveness of cancer therapies.
Telehealth received a boost this week when UnitedHealth announced that through its coverage for doctor visits via telemedicine, 20 million Americans could access telemedicine and receive coverage for it by next year.
Thomas Morrow, MD, wrote in a contributed article to AJMC.com that behavior modifications are the keys to improving health outcomes. Dr Morrow is just one of AJMC.com's many contributors. You can see more here. If you are interested in becoming an AJMC.com contributor sign up here.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
